PATENT CLAIM ANALYSIS

Application Number: 16153420
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["435", "320100"]

Abstract:
Provided herein are compositions and methods for selective expression of a transgene. Compositions and methods for selective expression of a transgene comprise one or more human regulatory elements, which, when operably linked to a transgene, can facilitate selective expression of a transgene (e.g., cell-type selective expression) in a target cell as compared to at least one or more non-target cells.

Claim (Index 3):
The nucleic acid cassette of  claim 2 , wherein the DNA binding protein is a transcriptional activator that modulates an endogenous SCN1A gene.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 97.0
- Lexical Diversity: 1.61905
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16153401', '16153433', '15125066', '15737918', '14004379']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6190760923286468
- 35 USC 102 Novelty (BERT): 0.7101280228082855
- Combined Prediction Score: 0.6281812853766107
- Mean Citation Score: 468.007158
- Max Citation Score: 741.85175
- Similarity Product: 739.5297843594552

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test